ResMed Inc. (RMD) Total liabilities 2016–2025
ResMed Inc. (RMD) total liabilities at each fiscal year-end, per SEC filings.
$2.2BFY2025 · since FY2016: $1.6B → $2.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.2B | +9.9% |
| FY2024 | $2.0B | -23.4% |
| FY2023 | $2.6B | +51.1% |
| FY2022 | $1.7B | -5.8% |
| FY2021 | $1.8B | -11.9% |
| FY2020 | $2.1B | +2.7% |
| FY2019 | $2.0B | +102.5% |
| FY2018 | $1.0B | -33.4% |
| FY2017 | $1.5B | -3.4% |
| FY2016 | $1.6B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice